Liuwei Dihuang soft capsules attenuates endothelial cell apoptosis to prevent atherosclerosis through GPR30-mediated regulation in ovariectomized ApoE-deficient mice
Bibliographic Data
Breast cancer · Estrogen · Estrogen receptor · GPER · Homocysteine · Hyperhomocysteinemia · Menopause · Ovariectomized rat · Atherosclerosis and Cardiovascular Diseases · Cholesterol and Lipid Metabolism · Estrogen and related hormone effects · Medicine · Endocrinology · Internal Medicine · Pharmacology
Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway
Gengnianshou formula inhibits estrogen deficiency induced obesity via an HSPA5-associated phosphatidylcholine (PC) regulatory pathway
Liuwei Dihuang prevents postmenopausal atherosclerosis and endothelial cell apoptosis via inhibiting DNMT1-medicated ERα methylation
LiuweiDihuang improved cognitive functions in Samp8 mice by inhibiting COX-2 expression and subsequent neuroinflammation
Qixian granule inhibits ferroptosis in vascular endothelial cells by modulating TRPML1 in the lysosome to prevent postmenopausal atherosclerosis
Effects and mechanisms of Danshen-Shanzha herb-pair for atherosclerosis treatment using network pharmacology and experimental pharmacology
Liuwei Dihuang soft capsules inhibits the phenotypic conversion of VSMC to prevent the menopausal atherosclerosis by up-regulating the expression of myocardin
| Unique citing works | 7 |
|---|---|
| Citations per year | 1 |
| Citation span | 2019 - 2026 (8) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 7 |